DIPHARMA FRANCIS S.R.L.

Please note: DIPHARMA FRANCIS S.R.L. is an Italian company, not based in India.

It is primarily a MANUFACTURER.

Company Introduction

DIPHARMA FRANCIS S.R.L. is a leading global Contract Development and Manufacturing Organization (CDMO) and a manufacturer of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Headquartered in Italy, the company has a long-standing history and extensive expertise in the pharmaceutical sector, spanning over 70 years.

Dipharma specializes in the research, development, and production of high-quality, complex APIs for a wide range of therapeutic areas. They operate state-of-the-art manufacturing facilities, primarily located in Italy, which comply with stringent international quality standards such as cGMP (current Good Manufacturing Practices).

Their business model is centered on manufacturing and providing specialized services, including process development, scale-up, and commercial manufacturing, to other pharmaceutical companies worldwide. While they engage in the sale and distribution of their manufactured products globally, their core identity and operations are those of a manufacturer, not primarily a trader of third-party goods.

DIPHARMA FRANCIS S.R.L. is an Italian pharmaceutical company, not an Indian one. They specialize in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. While they do not manufacture in India, they supply their products globally, including to pharmaceutical companies in India.

Their products primarily consist of:

Active Pharmaceutical Ingredients (APIs)

Advanced Intermediates

These products are utilized in the formulation of various pharmaceutical drugs across several therapeutic areas, including but not limited to:

Oncology

Central Nervous System (CNS) disorders

Cardiovascular diseases

Anti-infective treatments

Anti-inflammatory conditions

Metabolic disorders